SCHEMBL874873

SCHEMBL874873

CCC(O)c1ccc(C)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
PGR P06401 2/20 0.42
CHRNA7 P36544 1/20 0.41
TDP1 Q9NUW8 3/20 0.40
ACHE P22303 3/20 0.40
CYP2C9 P11712 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
ESR1 P03372 1/20 0.39
CHRM2 P08172 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
AR P10275 1/20 0.39
CHRM1 P11229 1/20 0.39
ALOX15 P16050 1/20 0.39
DRD1 P21728 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921442 1.00 LMNA (0.62) LMNAALDH1A1MAPTSMN1; SMN2PGR
SCHEMBL4576404 1.00 LMNA (0.62) LMNAALDH1A1MAPTSMN1; SMN2PGR
SCHEMBL9498632 0.93 LMNA (0.56) LMNAALDH1A1MAPTSMN1; SMN2PGR
SCHEMBL1607138 0.89 LMNA (0.75) LMNAALDH1A1MAPTSMN1; SMN2PGR
SCHEMBL8186503 0.83 ALDH1A1 (0.47) LMNAALDH1A1MAPTSMN1; SMN2CHRNA7
SCHEMBL29861210 0.82 LMNA (0.65) LMNAALDH1A1MAPTSMN1; SMN2PGR
SCHEMBL540784 0.81 ALDH1A1 (0.42) LMNAALDH1A1MAPTSMN1; SMN2CHRNA7
SCHEMBL13965237 0.81 LMNA (0.42) LMNAALDH1A1MAPTSMN1; SMN2PGR
SCHEMBL6134241 0.80 TSHR (0.46) LMNAALDH1A1MAPTSMN1; SMN2CHRNA7
SCHEMBL12610437 0.80 ESR1 (0.62) LMNAALDH1A1MAPTSMN1; SMN2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118955244-A Method for preparing primary alcohol by homogeneously catalyzing and reducing carboxylic acid derivative by using N-heterocyclic carbene copper complex 延安大学 2024-11-15 CN disclosed
CN-118344371-A Azaspiro compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-07-16 CN disclosed
EP-3397629-B1 METALLOENZYME INHIBITOR COMPOUNDS NQP 1598 LTD (KY) 2023-04-19 EP disclosed
CN-115896187-A Method for preparing prochiral ketone compound by biological oxidation through continuous flow device 南京工业大学 2023-04-04 CN disclosed
US-20220220068-A1 FUNGICIDAL ARYL AMIDINES CORTEVA AGRISCIENCE LLC (US) 2022-07-14 US disclosed
CN-113613494-A Fungicidal arylamidines 科迪华农业科技有限责任公司 2021-11-05 CN disclosed
CN-108821931-B Catalytic oxidation synthesis method of benzoic acid compound 浙江工业大学 2021-03-30 CN disclosed
CN-112165940-A OX2R compound 德克萨斯州立大学董事会 2021-01-01 CN disclosed
WO-2020237131-A1 FUNGICIDAL ARYL AMIDINES DOW AGROSCIENCES LLC (US) 2020-11-26 WO disclosed
US-10335775-B2 Magnetically separable iron-based heterogeneous catalysts for dehydrogenation of alcohols and amines COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2019-07-02 US disclosed
EP-0450995-B1 New propanamines, their pharmacological properties and their therapeutical applications, notably as anti-diarrhoea agents JOUVEINAL SA (FR) 1994-06-08 EP disclosed
EP-0354655-B1 1-PHENYL-1-PROPANOL DERIVATIVES CHISSO CORPORATION (JP) 1993-04-07 EP disclosed
EP-0523697-A1 Color-developing compositions and their use MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-01-20 EP disclosed
US-5143938-A PROPANAMINES, THEIR PHARMACOLOGICAL PROPERTIES AND THEIR APPLICATION FOR THERAPEUTIC IN PARTICULAR ANTIDIARRHEAL, PURPOSES JOUVEINAL S.A. (FR) 1992-09-01 US disclosed
US-5076947-A Optically active; free from temperature dependence CHISSO CORPORATION (JP) 1991-12-31 US disclosed
EP-0450995-A1 New propanamines, their pharmacological properties and their therapeutical applications, notably as anti-diarrhoea agents JOUVEINAL S.A. (FR) 1991-10-09 EP disclosed
US-5023366-A Reacted with a benzyl halide, alcohol or ether; for pressure sensitive elements MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1991-06-11 US disclosed
EP-0354655-A2 1-Phenyl-1-propanol derivatives CHISSO CORPORATION (JP) 1990-02-14 EP disclosed
EP-0285880-A2 Plant growth regulating agent BASF Aktiengesellschaft (DE) 1988-10-12 EP disclosed
EP-0268878-A2 Salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal salts of the copolymers and color-developing sheets employing the agents MITSUI TOATSU CHEMICALS, Inc. (JP) 1988-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220220068-A1 FUNGICIDAL ARYL AMIDINES CYP1A1, CYP1A2, CYP1B1 LMNA 3813/4885ALDH1A1 105/4885MAPT 4011/4885
US-10335775-B2 Magnetically separable iron-based heterogeneous catalysts for dehydrogenation of alcohols and amines ADH1A, ADH1C, ADH5 LMNA 2041/4885ALDH1A1 97/4885MAPT 1746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.